The King Hussein Cancer Center (KHCC), the largest specialised cancer institution in the Middle East, plays a strategic role in the MILenARI consortium. With a highly active Bone Marrow Transplant Programme and newly built cell therapy facilities, KHCC is poised to become a regional hub for academic CAR‑T development.
Scaling-up advanced lentiviral (LV) and CAR-T academic production across the Mediterranean region